The UK’s innovative life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines.
Innovation Orbit 2026 is FI Group by EPSA’s international guide to grants, R&D tax credits and public incentives for businesses planning R&D, CAPEX, digital transformation or decarbonisation projects.
KQ Labs, a leading accelerator that has helped early-stage life sciences innovators raise over £230 million, is now accepting applications for its ninth programme
The second in our series of skills webinars for the BIA Finance and Tax Community explored the key considerations for biotech companies expanding overseas, with insights and reflections from advisors and company leaders with firsthand international experience.
With $47 million in seed funding now secured, TRIMTECH Therapeutics is accelerating development of its TRIMTAC and TRIMGLUE portfolio — a novel approach to eliminating disease-causing proteins.
IMU Biosciences announce their new strategic partnership with Waters Biosciences to accelerate the development of IMU’s next-generation AI-powered High Definition (HD) Immunology Platform. The partnership will bring together Waters Biosciences’ advanced flow cytometry and single-cell technologies with IMU's HD analysis and proprietary AI and machine learning analytics to turn complex immune data into insights at scale across discovery, translational, and clinical research applications.
